Gregory A. Odle
Known title: Executive Vice PresidentCIK: 0001719088
Associated companies
Transaction History
| KIDS | ▼ Sell | Open Market | 8,433 | $145K | 3/16/2026 | View on chart |
| KIDS | ▲ Buy | Grant | 47,380 | $0 | 3/15/2026 | View on chart |
| KIDS | ▼ Sell | Open Market | 5,359 | $133K | 3/18/2025 | View on chart |
| KIDS | ▲ Buy | Grant | 38,773 | $0 | 3/15/2025 | View on chart |
| KIDS | ▲ Buy | Grant | 34,901 | $0 | 6/11/2024 | View on chart |
| KIDS | ▼ Sell | Open Market | 2,768 | $76K | 3/11/2024 | View on chart |
| KIDS | ▼ Sell | Open Market | 3,333 | $167K | 4/27/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 828 | $41K | 4/25/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 644 | $32K | 4/21/2023 | View on chart |
| KIDS | ▲ Buy | Grant | 19,617 | $0 | 3/15/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 3,421 | $151K | 3/6/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 1,195 | $60K | 2/2/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 80 | $4K | 1/20/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 1,771 | $80K | 1/13/2023 | View on chart |
| KIDS | ▼ Sell | Open Market | 229 | $10K | 1/9/2023 | View on chart |
| KIDS | ▲ Buy | Grant | 12,364 | $0 | 3/15/2022 | View on chart |
| KIDS | ▼ Sell | Open Market | 4,108 | $236K | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
OrthoPediatrics Reports 1,000th PNP Nail Implantation
OrthoPediatrics announced that its PNP Tibia Nail has reached 1,000 implantations, a milestone highlighting product adoption. Separately, the company is listed among stocks seeing action from activist investors. These developments provide context for the stock's current position within its 52-week range.
OrthoPediatrics Reports 1,000th PNP Nail Implantation. OrthoPediatrics announced that its PNP Tibia Nail has reached 1,000 implantations, a milestone highlighting product adoption. Separately, the company is listed among stocks seeing action from activist investors. These developments provide context for the stock's current position within its 52-week range.